Pharmacokinetics and Exposure-Response Relationship of Belimumab Administered Subcutaneously to SLE Patients

被引：0
|
作者：
Struemper, Herbert [1 ]
Thapar, Mita [2 ]
Gordon, David [3 ]
Roth, David [3 ]
机构：
[1] PAREXEL, Quantitat Clin Dev, Durham, NC USA
[2] ICON, Marlow, Bucks, England
[3] GSK, Philadelphia, PA USA
来源：
ARTHRITIS & RHEUMATOLOGY | 2016年 / 68卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
756
引用
收藏
页数：2
相关论文
共 50 条
  • [41] INEFFICACY OF BELIMUMAB IN SLE PATIENTS WHO LOSE RESPONSE TO RITUXIMAB
    Ul Hassan, Sabih
    Yusof, Mohammad Y. M.
    Dutton, Katherine
    Dass, Shouvik
    Vital, Edward
    RHEUMATOLOGY, 2019, 58 : 93 - 93
  • [42] Population pharmacokinetics and exposure-response relationship of trastuzumab and bevacizumab in early-stage breast cancer
    Petitcollin, A.
    Azzopardi, N.
    Pierga, J. Y.
    Ternant, D.
    Navarro-Teulon, I
    Desvignes, C.
    Mouret-Reynier, M. A.
    Coudert, B.
    Paintaud, G.
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 77 (12) : 1861 - 1873
  • [43] Confounding mitigation for the exposure-response relationship of bevacizumab in colorectal cancer patients
    Lobet, Sarah
    Caulet, Morgane
    Paintaud, Gilles
    Azzopardi, Nicolas
    Desvignes, Celine
    Chautard, Romain
    Borg, Christophe
    Capitain, Olivier
    Ferru, Aurelie
    Bouche, Olivier
    Lecomte, Thierry
    Ternant, David
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2024, 90 (04) : 976 - 986
  • [44] Is there an Exposure-Response Relationship for Nivolumab in Real-World NSCLC Patients?
    Bellesoeur, Audrey
    Ollier, Edouard
    Allard, Marie
    Hirsch, Laure
    Boudou-Rouquette, Pascaline
    Arrondeau, Jennifer
    Thomas-Schoemann, Audrey
    Tiako, Manuela
    Khoudour, Nihel
    Chapron, Jeanne
    Giraud, Frederique
    Wislez, Marie
    Damotte, Diane
    Lupo, Audrey
    Vidal, Michel
    Alexandre, Jerome
    Goldwasser, Francois
    Tod, Michel
    Blanchet, Benoit
    CANCERS, 2019, 11 (11)
  • [45] Characterization of brivanib pharmacokinetics and exposure-response (E-R): Relationship of fatigue in patients with advanced and metastatic solid tumors
    Wang, X.
    Syed, S.
    Masson, E.
    Walters, I. B.
    Roy, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [46] Rilotumumab Exposure-Response Relationship in Patients with Advanced or Metastatic Gastric Cancer
    Doshi, Sameer
    Gisleskog, Per Olsson
    Zhang, Yilong
    Zhu, Min
    Oliner, Kelly S.
    Loh, Elwyn
    Ruixo, Juan Jose Perez
    CLINICAL CANCER RESEARCH, 2015, 21 (11) : 2453 - 2461
  • [47] Assessment of exposure-response relationship for bevacizumab in patients with metastatic colorectal cancer
    Pena-Cabia, Silvia
    Royuela Vicente, Ana
    Ramos Diaz, Ruth
    Gutierrez Nicolas, Fernando
    Penalver Vera, Angela
    Siso Garcia, Isabel
    Hitt Sabag, Ricardo
    Garcia Lacalle, Concepcion
    Pena-Cabia, Ana
    Iglesias-Peinado, Irene
    Garcia Diaz, Benito
    Lopez-Martin, Ana
    BIOMEDICINE & PHARMACOTHERAPY, 2021, 141
  • [48] CHARACTERIZATION OF ABATACEPT PHARMACOKINETICS AND EXPOSURE-RESPONSE RELATIONSHIP IN SUPPORT OF SUBCUTANEOUS DOSE FOR JAPANESE RHEUMATOID ARTHRITIS
    Hasegawa, M.
    Roy, A.
    Imai, Y.
    Hiraoka, M.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2013, 93 : S45 - S45
  • [49] Population pharmacokinetics and exposure-response of filgotinib in patients with moderate to severe Crohn's disease
    Sharma, Shringi
    Xin, Yan
    Gao, Yuying
    Namour, Florence
    Mathias, Anita
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2016, 43 : S36 - S36
  • [50] Population pharmacokinetics and exposure-response modeling and simulation for evolocumab in healthy volunteers and patients with hypercholesterolemia
    Kuchimanchi, Mita
    Grover, Anita
    Emery, Maurice G.
    Somaratne, Ransi
    Wasserman, Scott M.
    Gibbs, John P.
    Doshi, Sameer
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2018, 45 (03) : 505 - 522
12345